Get started
Author

Andrea Salotti

ORCID: 0009-0000-2633-5480
Observed ORCID: 0009-0000-2633-5480
OpenAlex ID: A5005471801
Interrelationship between COVID-19 and Coagulopathy: Pathophysiological and Clinical Evidence
2023 · Beatrice Ragnoli, Beatrice Da Re, et al. · International Journal of Molecular Sciences · 38
PDF
Functional Progression after Dose Suspension or Discontinuation of Nintedanib in Idiopathic Pulmonary Fibrosis: A Real-Life Multicentre Study
2024 · Barbara Ruaro, Andrea Salotti, et al. · Pharmaceuticals · 28
PDF
Comorbidities’ Effect on IPF: Pathogenesis and Management
2025 · Andrea Salotti, Maria Chianese, et al. · Biomedicines · 9
PDF
The Impact of Comorbidities on the Discontinuation of Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis
2025 · Stefano Kette, Nicolò Reccardini, et al. · Pharmaceuticals · 8
Existence and relevance of fulminant severe community-acquired pneumonia
2025 · Francesco Salton, Jesús Villar, et al. · Pneumonia · 4
PDF
Cardiac sarcoidosis recurrence post-heart transplant: A critical literature and case report.
2025 · Andrea Salotti, Lucrezia Mondini, et al. · Europe PMC (PubMed Central) · 1
PDF
The onset of sarcoidosis in relation to tattoos: Focus on the treatment landscape. A critical literature review and case report.
2026 · Giorgio Monteleone, Andrea Salotti, et al. · Sarcoidosis vasculitis and diffuse lung diseases
PDF
Works count: 7
Citation count: 88
H-index: 4
I10-index: 2
Year
Topic
Type